Oxaborole analogs and uses thereof

US10961261B2 · kind B2 · utility

Assignees

• Anacor Pharmaceuticals, LLC · CA
• The Government of the United States, as represented by the Secretaryof the Army · US

Inventors

• Robert T. Jacobs · Palo Alto, US
• Yang Liu · Columbus, US
• Richard J. Sciotti · Saline, US
• Jason D. Speake · Durham, US
• Gavin Alistair Whitlock · Sandwich, GB
• Paul Alan Glossop · Sandwich, GB
• Charles Eric Mowbray · Sandwich, GB
• Delphine Françoise Monique Launay · Ornex, FR
• Stephen John Robinson · Geneva, CH

Key dates

• Filing date: Mar 1, 2018
• Grant date: Mar 30, 2021
• Expiry date: Mar 1, 2038

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02A50/30
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

This application describes compounds, compositions, and methods which are useful in treating, preventing, inhibiting, ameliorating, or eradicating the pathology and/or symptomology of a disease caused by a parasite.